Stada Investors OK Sweetened €4.12B Bain, Cinven Buyout
Enough of Stada Arzneimittel AG investors have backed Bain Capital's and Cinven's sweetened €4.12 billion ($4.8 billion) takeover of the German pharmaceutical company for it to move forward, after an earlier...To view the full article, register now.
Already a subscriber? Click here to view full article